news
Bottles of Coca-Cola are pictured during a news conference in Paris, France, April 20, 2017. REUTERS/Benoit Tessier 

 

Slaughter and May, Villaraza & Angangco, Skadden, Arps, Slate, Meagher & Flom, SyCip Salazar Hernandez & Gatmaitan have advised the buyers on a $1.8 billion acquisition of Coca-Cola Beverages Philippines (CCBPI) from Coca-Cola.

Slaughters and V&A represented bottler Coca-Cola Europacific Partners (CCEP), while Skadden and SyCipLaw acted for Aboitiz Equity Ventures.

With this acquisition, CCEP aims to become the world's largest Coca-Cola bottler by revenue and volumes by expanding in Asia, Reuters reported. The deal will be in cash, and the ownership of CCBPI will be divided 60:40 between CCEP and Aboitiz upon completion, Reuters added.

The Slaughter and May team was led by partners Roland Turnill, Robert Innes, Claire Cooke, Jordan Ellison, Duncan Blaikie and Charles Osborne. The Villaraza & Angangco team was led by senior partner Franchette M. Acosta and partner Kristin Charisse C. Siao.

Meanwhile, the Skadden team was headed by partners Jonathan Stone and Rajeev Duggal, and includes partners Andrew Foster, Rory McAlpine and Victor Hollender, and partner Arlene M. Maneja shepherded the SyCipLaw team.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Deals

Weil, Wong & Partners guide $2.6 bln Malaysia airport deal

by Nimitt Dixit |

U.S law firm Weil, Gotshal & Manges and Wong & Partners, Baker McKenzie’s Malaysia member firm, have guided investment firm Global Infrastructure Partners (GIP) and a consortium led by Khazanah Nasional Bhd, respectively, on a $2.6 billion take-private offer for Malaysia Airports Holdings (MAH).

Appointments

Nishimura continues SEA growth with energy partner

by Nimitt Dixit |

Japanese Big Six law firm Nishimura & Asahi has continued the planned expansion of its Southeast Asia offerings with the addition of energy-focused finance and M&A partner Sean Conaty.

Deals

GT, Goodwin act as Japan's Ono buys U.S. drugmaker for $2.4 bln

by Asian Legal Business《亚洲法律杂志》 |

Greenberg Traurig has represented Japan’s Ono Pharmaceutical Co on its $2.4 billion acquisition of  U.S.-based cancer drugmaker Deciphera, which was advised by Goodwin Procter.